Tag: mesalamine
Alembic Pharmaceuticals gets FDA final approval for ulcerative colitis generic drug
Alembic Pharmaceuticals said that it has secured final approval for its abbreviated new drug application (ANDA) for Mesalamine Extended-Release Capsules USP, 0.375 g from the ... Read More
Zydus Cadila gets FDA approval for Mesalamine Extended-Release Capsules
Zydus Cadila said that it has secured final approval from the US Food and Drug Administration (FDA) to market Mesalamine Extended-Release Capsules in the strength ... Read More
Teva launches generic version of Delzicol delayed-release capsules in US
Israeli pharma company Teva Pharmaceuticals has launched a generic version of Delzicol (mesalamine) 400mg delayed-release capsules in the US. Mesalamine Delayed-Release capsules are an aminosalicylate, ... Read More